We used the CRISPR-Cas9 nuclease system to generate RCAN1.4-SEdistal knockout breast cancer cells with deletion of the ~ 20-kb RCAN1.4 composite enhancer by introduction of a pair of sgRNAs (Fig. 3d). Here, RCAN1 is linked to breast carcinoma.